Similarity Score |
Similarity Level |
Drug ID |
Developmental Stage |
0.8274 |
Intermediate Similarity |
NPD8150 |
Discontinued |
0.8187 |
Intermediate Similarity |
NPD7879 |
Clinical (unspecified phase) |
0.8125 |
Intermediate Similarity |
NPD7075 |
Discontinued |
0.8112 |
Intermediate Similarity |
NPD1470 |
Approved |
0.805 |
Intermediate Similarity |
NPD7096 |
Clinical (unspecified phase) |
0.8 |
Intermediate Similarity |
NPD1509 |
Clinical (unspecified phase) |
0.8 |
Intermediate Similarity |
NPD7473 |
Discontinued |
0.7937 |
Intermediate Similarity |
NPD7819 |
Suspended |
0.7927 |
Intermediate Similarity |
NPD6232 |
Discontinued |
0.7911 |
Intermediate Similarity |
NPD3226 |
Approved |
0.7871 |
Intermediate Similarity |
NPD3300 |
Phase 2 |
0.7862 |
Intermediate Similarity |
NPD4380 |
Phase 2 |
0.7832 |
Intermediate Similarity |
NPD1201 |
Approved |
0.7829 |
Intermediate Similarity |
NPD5408 |
Approved |
0.7829 |
Intermediate Similarity |
NPD5404 |
Approved |
0.7829 |
Intermediate Similarity |
NPD5405 |
Approved |
0.7829 |
Intermediate Similarity |
NPD5406 |
Approved |
0.7826 |
Intermediate Similarity |
NPD2393 |
Clinical (unspecified phase) |
0.7806 |
Intermediate Similarity |
NPD6190 |
Approved |
0.779 |
Intermediate Similarity |
NPD8319 |
Approved |
0.779 |
Intermediate Similarity |
NPD8320 |
Phase 1 |
0.7784 |
Intermediate Similarity |
NPD6535 |
Approved |
0.7784 |
Intermediate Similarity |
NPD6534 |
Approved |
0.7778 |
Intermediate Similarity |
NPD8312 |
Approved |
0.7778 |
Intermediate Similarity |
NPD8313 |
Approved |
0.7778 |
Intermediate Similarity |
NPD2346 |
Discontinued |
0.7771 |
Intermediate Similarity |
NPD2533 |
Approved |
0.7771 |
Intermediate Similarity |
NPD2534 |
Approved |
0.7771 |
Intermediate Similarity |
NPD2532 |
Approved |
0.7764 |
Intermediate Similarity |
NPD6801 |
Discontinued |
0.7764 |
Intermediate Similarity |
NPD1934 |
Approved |
0.7763 |
Intermediate Similarity |
NPD651 |
Clinical (unspecified phase) |
0.775 |
Intermediate Similarity |
NPD6599 |
Discontinued |
0.7746 |
Intermediate Similarity |
NPD8434 |
Phase 2 |
0.7735 |
Intermediate Similarity |
NPD7435 |
Discontinued |
0.7727 |
Intermediate Similarity |
NPD970 |
Clinical (unspecified phase) |
0.7707 |
Intermediate Similarity |
NPD6799 |
Approved |
0.7688 |
Intermediate Similarity |
NPD8055 |
Clinical (unspecified phase) |
0.7669 |
Intermediate Similarity |
NPD5402 |
Approved |
0.7669 |
Intermediate Similarity |
NPD3817 |
Phase 2 |
0.7667 |
Intermediate Similarity |
NPD6780 |
Approved |
0.7667 |
Intermediate Similarity |
NPD6782 |
Approved |
0.7667 |
Intermediate Similarity |
NPD6781 |
Approved |
0.7667 |
Intermediate Similarity |
NPD6777 |
Approved |
0.7667 |
Intermediate Similarity |
NPD6778 |
Approved |
0.7667 |
Intermediate Similarity |
NPD6779 |
Approved |
0.7667 |
Intermediate Similarity |
NPD6776 |
Approved |
0.7658 |
Intermediate Similarity |
NPD7422 |
Clinical (unspecified phase) |
0.7658 |
Intermediate Similarity |
NPD4378 |
Clinical (unspecified phase) |
0.7654 |
Intermediate Similarity |
NPD7699 |
Phase 2 |
0.7654 |
Intermediate Similarity |
NPD7700 |
Phase 2 |
0.7628 |
Intermediate Similarity |
NPD4628 |
Phase 3 |
0.7622 |
Intermediate Similarity |
NPD3882 |
Suspended |
0.7622 |
Intermediate Similarity |
NPD4868 |
Clinical (unspecified phase) |
0.7619 |
Intermediate Similarity |
NPD6167 |
Clinical (unspecified phase) |
0.7619 |
Intermediate Similarity |
NPD6166 |
Phase 2 |
0.7619 |
Intermediate Similarity |
NPD6168 |
Clinical (unspecified phase) |
0.7616 |
Intermediate Similarity |
NPD943 |
Approved |
0.76 |
Intermediate Similarity |
NPD3764 |
Approved |
0.7597 |
Intermediate Similarity |
NPD2935 |
Discontinued |
0.7595 |
Intermediate Similarity |
NPD7390 |
Discontinued |
0.7588 |
Intermediate Similarity |
NPD5844 |
Phase 1 |
0.7576 |
Intermediate Similarity |
NPD4381 |
Clinical (unspecified phase) |
0.7557 |
Intermediate Similarity |
NPD8397 |
Clinical (unspecified phase) |
0.7545 |
Intermediate Similarity |
NPD6959 |
Discontinued |
0.7535 |
Intermediate Similarity |
NPD405 |
Clinical (unspecified phase) |
0.7529 |
Intermediate Similarity |
NPD3751 |
Discontinued |
0.7514 |
Intermediate Similarity |
NPD4338 |
Clinical (unspecified phase) |
0.75 |
Intermediate Similarity |
NPD2801 |
Approved |
0.75 |
Intermediate Similarity |
NPD1549 |
Phase 2 |
0.7487 |
Intermediate Similarity |
NPD7874 |
Approved |
0.7487 |
Intermediate Similarity |
NPD7875 |
Clinical (unspecified phase) |
0.7485 |
Intermediate Similarity |
NPD7804 |
Clinical (unspecified phase) |
0.7485 |
Intermediate Similarity |
NPD5494 |
Approved |
0.7485 |
Intermediate Similarity |
NPD7411 |
Suspended |
0.747 |
Intermediate Similarity |
NPD3749 |
Approved |
0.7457 |
Intermediate Similarity |
NPD6559 |
Discontinued |
0.7455 |
Intermediate Similarity |
NPD8443 |
Clinical (unspecified phase) |
0.7453 |
Intermediate Similarity |
NPD5403 |
Approved |
0.7452 |
Intermediate Similarity |
NPD7421 |
Clinical (unspecified phase) |
0.7451 |
Intermediate Similarity |
NPD230 |
Phase 1 |
0.7446 |
Intermediate Similarity |
NPD7696 |
Phase 3 |
0.7446 |
Intermediate Similarity |
NPD7697 |
Approved |
0.7446 |
Intermediate Similarity |
NPD7698 |
Approved |
0.7436 |
Intermediate Similarity |
NPD1552 |
Clinical (unspecified phase) |
0.7436 |
Intermediate Similarity |
NPD1550 |
Clinical (unspecified phase) |
0.7427 |
Intermediate Similarity |
NPD3818 |
Discontinued |
0.7419 |
Intermediate Similarity |
NPD1510 |
Phase 2 |
0.7419 |
Intermediate Similarity |
NPD2799 |
Discontinued |
0.7405 |
Intermediate Similarity |
NPD8166 |
Discontinued |
0.7405 |
Intermediate Similarity |
NPD7871 |
Phase 2 |
0.7405 |
Intermediate Similarity |
NPD7870 |
Phase 2 |
0.7399 |
Intermediate Similarity |
NPD7993 |
Clinical (unspecified phase) |
0.7399 |
Intermediate Similarity |
NPD6797 |
Phase 2 |
0.7391 |
Intermediate Similarity |
NPD1512 |
Approved |
0.738 |
Intermediate Similarity |
NPD7701 |
Phase 2 |
0.7362 |
Intermediate Similarity |
NPD5808 |
Clinical (unspecified phase) |
0.7356 |
Intermediate Similarity |
NPD7251 |
Discontinued |
0.7354 |
Intermediate Similarity |
NPD7801 |
Approved |
0.7341 |
Intermediate Similarity |
NPD7074 |
Phase 3 |
0.7333 |
Intermediate Similarity |
NPD6212 |
Phase 3 |
0.7333 |
Intermediate Similarity |
NPD6214 |
Clinical (unspecified phase) |
0.7333 |
Intermediate Similarity |
NPD6213 |
Phase 3 |
0.7329 |
Intermediate Similarity |
NPD5401 |
Approved |
0.732 |
Intermediate Similarity |
NPD6663 |
Approved |
0.7314 |
Intermediate Similarity |
NPD5028 |
Approved |
0.7314 |
Intermediate Similarity |
NPD4955 |
Approved |
0.7314 |
Intermediate Similarity |
NPD36 |
Approved |
0.7314 |
Intermediate Similarity |
NPD4954 |
Approved |
0.7314 |
Intermediate Similarity |
NPD5026 |
Approved |
0.7314 |
Intermediate Similarity |
NPD7808 |
Phase 3 |
0.7314 |
Intermediate Similarity |
NPD5034 |
Approved |
0.7312 |
Intermediate Similarity |
NPD7236 |
Approved |
0.731 |
Intermediate Similarity |
NPD7852 |
Clinical (unspecified phase) |
0.731 |
Intermediate Similarity |
NPD9545 |
Approved |
0.7308 |
Intermediate Similarity |
NPD3299 |
Clinical (unspecified phase) |
0.7296 |
Intermediate Similarity |
NPD3750 |
Approved |
0.7296 |
Intermediate Similarity |
NPD1878 |
Clinical (unspecified phase) |
0.7296 |
Intermediate Similarity |
NPD6398 |
Clinical (unspecified phase) |
0.7294 |
Intermediate Similarity |
NPD5710 |
Approved |
0.7294 |
Intermediate Similarity |
NPD5711 |
Approved |
0.7294 |
Intermediate Similarity |
NPD3787 |
Discontinued |
0.729 |
Intermediate Similarity |
NPD1607 |
Approved |
0.7289 |
Intermediate Similarity |
NPD1465 |
Phase 2 |
0.7285 |
Intermediate Similarity |
NPD5736 |
Approved |
0.7283 |
Intermediate Similarity |
NPD7054 |
Approved |
0.7273 |
Intermediate Similarity |
NPD7966 |
Clinical (unspecified phase) |
0.7273 |
Intermediate Similarity |
NPD4060 |
Phase 1 |
0.7273 |
Intermediate Similarity |
NPD7211 |
Clinical (unspecified phase) |
0.7273 |
Intermediate Similarity |
NPD1240 |
Approved |
0.7267 |
Intermediate Similarity |
NPD1164 |
Approved |
0.7267 |
Intermediate Similarity |
NPD1511 |
Approved |
0.7261 |
Intermediate Similarity |
NPD2796 |
Approved |
0.7257 |
Intermediate Similarity |
NPD5030 |
Phase 2 |
0.7256 |
Intermediate Similarity |
NPD7458 |
Discontinued |
0.7255 |
Intermediate Similarity |
NPD2313 |
Discontinued |
0.7247 |
Intermediate Similarity |
NPD5037 |
Approved |
0.7247 |
Intermediate Similarity |
NPD5038 |
Approved |
0.7241 |
Intermediate Similarity |
NPD7472 |
Approved |
0.7222 |
Intermediate Similarity |
NPD7410 |
Clinical (unspecified phase) |
0.7222 |
Intermediate Similarity |
NPD7004 |
Clinical (unspecified phase) |
0.7219 |
Intermediate Similarity |
NPD5537 |
Clinical (unspecified phase) |
0.7219 |
Intermediate Similarity |
NPD6234 |
Discontinued |
0.7202 |
Intermediate Similarity |
NPD7768 |
Phase 2 |
0.7191 |
Intermediate Similarity |
NPD5036 |
Approved |
0.7172 |
Intermediate Similarity |
NPD9493 |
Approved |
0.7159 |
Intermediate Similarity |
NPD7685 |
Pre-registration |
0.7159 |
Intermediate Similarity |
NPD8368 |
Discontinued |
0.7158 |
Intermediate Similarity |
NPD8151 |
Discontinued |
0.7153 |
Intermediate Similarity |
NPD2629 |
Approved |
0.7152 |
Intermediate Similarity |
NPD6100 |
Approved |
0.7152 |
Intermediate Similarity |
NPD6099 |
Approved |
0.7152 |
Intermediate Similarity |
NPD1551 |
Phase 2 |
0.7126 |
Intermediate Similarity |
NPD37 |
Approved |
0.7126 |
Intermediate Similarity |
NPD7799 |
Discontinued |
0.7115 |
Intermediate Similarity |
NPD6355 |
Discontinued |
0.7115 |
Intermediate Similarity |
NPD447 |
Suspended |
0.7112 |
Intermediate Similarity |
NPD6823 |
Phase 2 |
0.7107 |
Intermediate Similarity |
NPD1471 |
Phase 3 |
0.7107 |
Intermediate Similarity |
NPD8155 |
Clinical (unspecified phase) |
0.7107 |
Intermediate Similarity |
NPD2344 |
Approved |
0.7107 |
Intermediate Similarity |
NPD5762 |
Approved |
0.7107 |
Intermediate Similarity |
NPD7266 |
Discontinued |
0.7107 |
Intermediate Similarity |
NPD5763 |
Approved |
0.7105 |
Intermediate Similarity |
NPD6007 |
Clinical (unspecified phase) |
0.7105 |
Intermediate Similarity |
NPD2798 |
Approved |
0.7101 |
Intermediate Similarity |
NPD4967 |
Phase 2 |
0.7101 |
Intermediate Similarity |
NPD4966 |
Approved |
0.7101 |
Intermediate Similarity |
NPD4965 |
Approved |
0.7095 |
Intermediate Similarity |
NPD2932 |
Approved |
0.7095 |
Intermediate Similarity |
NPD3019 |
Approved |
0.7091 |
Intermediate Similarity |
NPD7239 |
Suspended |
0.7089 |
Intermediate Similarity |
NPD7033 |
Discontinued |
0.7081 |
Intermediate Similarity |
NPD7003 |
Approved |
0.7079 |
Intermediate Similarity |
NPD5035 |
Approved |
0.7073 |
Intermediate Similarity |
NPD6273 |
Approved |
0.7067 |
Intermediate Similarity |
NPD9269 |
Phase 2 |
0.7062 |
Intermediate Similarity |
NPD5031 |
Approved |
0.7062 |
Intermediate Similarity |
NPD5027 |
Approved |
0.7062 |
Intermediate Similarity |
NPD5029 |
Approved |
0.7039 |
Intermediate Similarity |
NPD8407 |
Phase 2 |
0.7032 |
Intermediate Similarity |
NPD6798 |
Discontinued |
0.7029 |
Intermediate Similarity |
NPD7228 |
Approved |
0.7018 |
Intermediate Similarity |
NPD919 |
Approved |
0.7006 |
Intermediate Similarity |
NPD5953 |
Discontinued |
0.7 |
Intermediate Similarity |
NPD2343 |
Clinical (unspecified phase) |
0.6995 |
Remote Similarity |
NPD7782 |
Clinical (unspecified phase) |
0.6995 |
Remote Similarity |
NPD7783 |
Phase 2 |
0.6982 |
Remote Similarity |
NPD5761 |
Phase 2 |
0.6982 |
Remote Similarity |
NPD5760 |
Phase 2 |
0.6981 |
Remote Similarity |
NPD3748 |
Approved |
0.6978 |
Remote Similarity |
NPD8360 |
Approved |
0.6978 |
Remote Similarity |
NPD8361 |
Approved |
0.6972 |
Remote Similarity |
NPD9266 |
Approved |
0.6972 |
Remote Similarity |
NPD74 |
Approved |
0.6968 |
Remote Similarity |
NPD5952 |
Clinical (unspecified phase) |
0.6966 |
Remote Similarity |
NPD6765 |
Approved |
0.6966 |
Remote Similarity |
NPD6764 |
Approved |
0.6954 |
Remote Similarity |
NPD1608 |
Approved |
0.6954
|
Remote Similarity |
NPD7184 |
Clinical (unspecified phase) |